Skip to Main Content

Paper Details

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.
J Clin Oncol
81
2018
Author NameAffiliation
Andrew M EvensRutgers Cancer Institute of New Jersey, Stanford University, Northwestern University Feinberg School of Medicine Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center Sonali M. Smith, University of Chicago, University of Texas MD Anderson Cancer Center, University of Nebraska, Tufts Medical Center, Memorial Sloan Kettering Cancer Center
Borko JovanovicRutgers Cancer Institute of New Jersey, Stanford University, Northwestern University Feinberg School of Medicine Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center Sonali M. Smith, University of Chicago, University of Texas MD Anderson Cancer Center, University of Nebraska, Tufts Medical Center, Memorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets